Dogs Walked 10 Days Faster After Spinal Surgery — Because of Light
In a controlled trial, dogs recovering from spinal disc surgery regained the ability to walk in a median of 3.5 days with photobiomodulation therapy versus 14 days without it (Draper et al., 2012). That is one of the most striking results in veterinary rehabilitation research, and it came from shining specific wavelengths of light on tissue.
Photobiomodulation (PBM) — formerly called low-level laser therapy or cold laser therapy — uses red (630-660 nm) and near-infrared (800-980 nm) light to stimulate mitochondrial function. Photons are absorbed by cytochrome c oxidase, upregulating ATP production, reducing reactive oxygen species, and modulating inflammatory signaling cascades including NF-kB.
The veterinary market is flooded with inexpensive LED devices marketed for home use alongside Class IV therapeutic lasers costing $15,000-$40,000. The biological effects — and the evidence — differ substantially depending on the device and protocol used.
Clinical Evidence in Dogs
Post-Surgical Recovery
The strongest veterinary evidence for PBM comes from post-surgical applications. Draper et al. (2012) conducted a controlled trial in dogs recovering from hemilaminectomy for intervertebral disc disease and found that PBM-treated dogs achieved ambulation significantly faster than control dogs (median 3.5 days vs. 14 days). This study used a Class IV laser at 980 nm with specific dosimetry protocols.
Kennedy et al. (2018) compared PBM to NSAID analgesia following tibial plateau leveling osteotomy (TPLO) for cruciate ligament disease. The study found that PBM provided comparable pain control to meloxicam in the early post-operative period, suggesting it may serve as an alternative or adjunct for dogs that cannot tolerate NSAIDs due to renal or gastrointestinal concerns.
Wound Healing
Kurach et al. (2015) evaluated PBM effects on open wound healing in dogs using a controlled design. PBM-treated wounds showed accelerated granulation tissue formation and earlier epithelialization compared to sham-treated controls. The effect was dose-dependent — too little energy produced no measurable benefit, while excessive energy impaired healing, demonstrating the biphasic dose-response (Arndt-Schulz) curve that characterizes PBM.
Pain Management
Renwick et al. (2022) conducted a scoping review of PBM in canine medicine and identified moderate evidence supporting analgesic effects in arthritis, post-surgical pain, and musculoskeletal conditions. The review noted significant heterogeneity in treatment protocols across studies, making direct comparisons difficult, but concluded that the overall direction of evidence supports PBM as an adjunctive analgesic modality.
PBM appears most useful for dogs with chronic musculoskeletal pain who are already receiving conventional therapy but need additional pain control, or for dogs that cannot tolerate standard analgesic medications. It is not a replacement for appropriate surgical intervention, weight management, or first-line pain medication.
Inflammation and Edema
PBM consistently reduces tissue edema and inflammatory markers in controlled studies. The mechanism involves downregulation of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) and upregulation of anti-inflammatory mediators. This makes it theoretically relevant to conditions characterized by chronic inflammation, including inflammatory bowel disease, atopic dermatitis, and degenerative joint disease.
However, the evidence for these specific applications in dogs remains preliminary, with most data extrapolated from rodent models or human clinical trials.
Dosimetry: Why Protocol Details Matter
The most common reason PBM fails in clinical practice is incorrect dosimetry. The therapeutic window is narrow:
- Wavelength: 630-660 nm (red) penetrates superficially (skin, mucous membranes); 800-980 nm (near-infrared) penetrates deeper (muscle, joint, nerve tissue). Choose wavelength based on target tissue depth.
- Power density: Therapeutic range is typically 10-50 mW/cm2 at the tissue surface. Below this, insufficient photons reach target chromophores. Above this, thermal effects dominate and can inhibit cellular function.
- Energy density (fluence): Most evidence supports 1-10 J/cm2 for superficial targets and 4-30 J/cm2 for deeper targets.
- Treatment duration: Depends on device output and target area size. Typical sessions last 2-15 minutes per treatment site.
- Frequency: Acute conditions respond to daily treatment for 5-7 days followed by tapering. Chronic conditions typically require 2-3 sessions per week for 4-6 weeks.
Coat color and density affect light penetration. Dark-coated dogs absorb more photons at the skin surface, reducing deep tissue delivery. Clipping hair over the treatment site improves energy delivery consistency.
Practical Guidance for Dog Owners
PBM is best applied by a veterinary professional with appropriate equipment and training:
- Seek a veterinary rehabilitation specialist (CCRP or CCRT certified) for PBM treatment
- Ask about the specific device used (Class, wavelength, power output) and the dosimetry protocol
- Expect a treatment trial of 6-8 sessions before evaluating response
- Track response using validated pain scores (Canine Brief Pain Inventory, Helsinki Chronic Pain Index) rather than subjective impressions
- Continue conventional therapy alongside PBM — it is additive, not substitutive
- Home-use LED devices generally lack sufficient power to achieve therapeutic doses in deep tissues, though they may provide superficial benefits for skin conditions
Cost for professional PBM sessions typically ranges from $30-$75 per treatment, with initial assessment fees of $75-$150. A 6-session trial represents a $250-$500 investment.
Limitations and Cautions
- PBM should not be applied over known or suspected malignant tumors — there is theoretical concern that enhanced cellular metabolism could accelerate tumor growth, though direct evidence in dogs is limited
- Evidence quality is moderate at best; many studies use small sample sizes and lack blinding
- Standardization of treatment protocols across the veterinary profession remains poor
- The consumer market for PBM devices includes many products with unsubstantiated claims and insufficient power for meaningful tissue effects
- PBM does not replace appropriate medical or surgical intervention for conditions requiring definitive treatment
- Individual response varies considerably, and non-responders should be identified within the trial period
Related Conditions
Related Longevity Science
- Therapeutic Laser for Dogs: Evidence Review
- Canine Physical Rehabilitation Evidence
- Multi-Modal Pain Management
Frequently Asked Questions
Is photobiomodulation the same as therapeutic laser?
Photobiomodulation is the updated, more precise term for what was previously called low-level laser therapy or cold laser therapy. The name change reflects that both laser and LED light sources can achieve the same biological effects when proper dosimetry is used.
Can I use a home laser device on my dog?
Consumer-grade LED devices may provide superficial benefits for skin conditions but generally lack sufficient power to deliver therapeutic doses to deep tissues like joints, muscles, or nerves. Professional-grade Class IV lasers deliver substantially more energy and are the devices used in published clinical trials.
How quickly does photobiomodulation work?
Some dogs show improvement after 1-2 sessions, but most require 4-6 sessions before meaningful clinical response is apparent. Post-surgical applications tend to show faster response than chronic pain conditions.
Are there any side effects?
PBM has an excellent safety profile when administered correctly. Rare adverse effects include transient warmth at the treatment site and occasional pain flares in the first 24 hours. Eye protection is mandatory during treatment to prevent retinal damage from direct or reflected laser light.
Bottom Line
Photobiomodulation has moderate evidence supporting its use as an adjunctive therapy for post-surgical recovery, wound healing, and chronic musculoskeletal pain in dogs. It works best when applied by trained professionals using appropriate equipment and dosimetry protocols, alongside — not instead of — conventional medical management.
References
- Draper WE et al. Low-level laser therapy reduces time to ambulation in dogs after hemilaminectomy. J Small Anim Pract. 2012;53(8):465-469.
- Kurach LM et al. The effect of low-level laser therapy on the healing of open wounds in dogs. Vet Surg. 2015;44(8):988-996.
- Kennedy KC et al. Laser therapy and NSAID comparison following TPLO. Vet Surg. 2018;47(2):159-165.
- Renwick SM et al. Photobiomodulation therapy in canine medicine: a scoping review. Top Companion Anim Med. 2022;47:100630.